A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/CF93FC0F.svg?ark=w1%2F20260515%2FCF93FC0F)](https://nobleid.org/work/w1/20260515/CF93FC0F)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors